The Discounted Cash Flow (DCF) valuation of Immunitybio Inc (IBRX) is (88,898.73) USD. With the latest stock price at 2.87 USD, the upside of Immunitybio Inc based on DCF is -3097616.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 9.3% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (182,084.89) - (59,007.62) | (88,898.73) |
| Upside | -6344521.3% - -2056114.7% | -3097616.6% |